Topical diclofenac: Moderate efficacy in actinic keratosis

Prescrire International

Volumn 13, Issue 72, 2004, Pages 138-139

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; EXCIPIENT; FLUOROURACIL; HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; DERMATOLOGICAL AGENT;

ACTINIC KERATOSIS; ARTICLE; BIOLOGICAL MODEL; CLINICAL PRACTICE; CLINICAL TRIAL; CONTACT DERMATITIS; CRYOTHERAPY; DESQUAMATION; DOSE RESPONSE; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG MARKETING; DRUG MECHANISM; DRUG TISSUE LEVEL; DRUG TOLERABILITY; DRUG UPTAKE; DRY SKIN; EPIDERMIS; GEL; HUMAN; IN VITRO STUDY; PAIN; PARESTHESIA; PHOTOSENSITIVITY DISORDER; PHYSICAL MEDICINE; PRURITUS; RECURRENCE RISK; SKIN DEFECT; SKIN IRRITATION; TREATMENT FAILURE; ANIMAL; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; INTRADERMAL DRUG ADMINISTRATION; POROKERATOSIS; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DERMATOLOGIC AGENTS; DICLOFENAC; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FLUOROURACIL; GELS; HUMANS; HYALURONIC ACID; POROKERATOSIS; TREATMENT OUTCOME;

EID: 16244402322     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Jarvis B and Figgitt DP "Topical 3 % diclofenac in 2,5 % hyaluronic acid gel" Am J Clin Dermatol 2003; 4 (3): 1-11.
2. Brown MB et al. "The effect of hyaluronan on the in vitro deposition of diclofenac within the skin" Int J Tiss Reac 1995; 17 (4): 133-140.
3. McEwan LE and Smith JG "Topical diclofenac/hyaluronic acid gel in the treatment of solar keratoses" Australas J Dermatol 1997: 38 (4): 187-189.
4. Gebauer K et al. "Topical diclofenac in hyaluronan gel for the treatment of solar keratoses" Australas J Dermatol 2003; 44 40-43.
5. Rivers JK et al. "Topical treatment of actinic keratoses with 3.0 % diclofenan in 2.5 % hyaluronan gel" Br J Dermatol 2002; 146: 94-100.
6. Wolf JE et al. "Topical 3.0 % diclofenac in 2.5 % hyaluronan gel in the treatment of actinic keratoses" Int J Dermatol 2001; 40: 709-713.
7. Food and Drug Administration "Solaraze - Summary of product characteristics" 6 pages.
8. Food and Drug administration - Center for Drug Evaluation and Research "Application number: 21-005-Medical review(s)" + "Amendments" 17 October 1999: 133 pages.